These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4632029)

  • 1. Autoregulation of the secretion of MSH in incubates of toad pars intermedia.
    Iturriza FC
    Gen Comp Endocrinol; 1973 Feb; 20(1):168-71. PubMed ID: 4632029
    [No Abstract]   [Full Text] [Related]  

  • 2. ELECTRON-MICROSCOPIC STUDY OF THE PARS INTERMEDIA OF THE PITUITARY OF THE TOAD BUFO ARENARUM.
    ITURRIZA FC
    Gen Comp Endocrinol; 1964 Oct; 4():492-502. PubMed ID: 14216257
    [No Abstract]   [Full Text] [Related]  

  • 3. Ultrastructure of the toad pars intermedia after the extirpation of the pars distalis.
    Rodríguez EM; Cuello CA
    J Ultrastruct Res; 1982 May; 79(2):207-22. PubMed ID: 6804641
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetylation of melanocyte-stimulating hormone and beta-endorphin in the pars intermedia of the perinatal pituitary gland in the mouse.
    Leenders HJ; Janssens JJ; Theunissen HJ; Jenks BG; van Overbeeke AP
    Neuroendocrinology; 1986; 43(2):166-74. PubMed ID: 2941692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactive alpha-melanotropin and beta-endorphin in the toad pars intermedia: dissociation in storage, secretion and subcellular localization.
    Loh YP; Li A; Gritsch HA; Eskay RL
    Life Sci; 1981 Oct; 29(15):1599-605. PubMed ID: 6272045
    [No Abstract]   [Full Text] [Related]  

  • 6. Secretion of melanocyte-stimulating hormone and adrenocorticotropin from transplanted pituitary pars intermedia in stressed and nonstressed rats.
    Iturriza FC; Eberle AN
    Neuroendocrinology; 1989 Jun; 49(6):610-6. PubMed ID: 2549438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal acetylation of melanophore-stimulating hormone in the pars intermedia of Xenopus laevis is a physiologically regulated process.
    Verburg-van Kemenade BM; Jenks BG; Smits RJ
    Neuroendocrinology; 1987 Oct; 46(4):289-96. PubMed ID: 2823159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N alpha-acetylation is linked to alpha-MSH release from pars intermedia of the amphibian pituitary gland.
    Martens GJ; Jenks BG; van Overbeeke AP
    Nature; 1981 Dec; 294(5841):558-60. PubMed ID: 6273748
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative immunohistochemical studies of gamma-melanocyte stimulating hormone (gamma-MSH) and adrenocorticotrophic hormone (ACTH) in the bovine and human pituitaries.
    Osamura RY; Watanabe K; Tanaka I; Nakai Y; Imura H
    Acta Endocrinol (Copenh); 1981 Apr; 96(4):458-63. PubMed ID: 6259862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanophore stimulating hormone: release inhibition by ring structures of neurohypophysial hormones.
    Hruby VJ; Smith CW; Bower A; Hadley ME
    Science; 1972 Jun; 176(4041):1331-2. PubMed ID: 4624585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life span changes in the presence of alpha-melanocyte-stimulating-hormone-containing cells in the human pituitary.
    Visser M; Swaab DF
    J Dev Physiol; 1979 Apr; 1(2):161-78. PubMed ID: 233377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of melanotropin release from the pars intermedia of the amphibian Xenopus laevis: evaluation of the involvement of serotonergic, cholinergic, or adrenergic receptor mechanisms.
    Verburg-van Kemenade BM; Jenks BG; van Overbeeke AP
    Gen Comp Endocrinol; 1986 Sep; 63(3):471-80. PubMed ID: 3557070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action potentials in gland cells of rat pituitary pars intermedia: inhibition by dopamine, an inhibitor of MSH secretion.
    Douglas WW; Taraskevich PS
    J Physiol; 1978 Dec; 285():171-84. PubMed ID: 745066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro formation of a MSH-releasing agent by hypothalamic extracts.
    Celis ME; Taleisnik S
    Experientia; 1971 Dec; 27(12):1481-2. PubMed ID: 5144873
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences in the release of melanocyte-stimulating hormone in vitro by rat pituitary glands collected at various times during the oestrous cycle.
    Vivas A; Celis ME
    J Endocrinol; 1978 Jul; 78(1):1-6. PubMed ID: 567239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionic requirements for melanophore-stimulating hormone (MSH) release.
    Bower A; Hadley ME
    Gen Comp Endocrinol; 1972 Aug; 19(1):147-58. PubMed ID: 4625838
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypothalamic and cerebral cortical inhibitors of a melanocyte-stimulating substance secreted by the pars distalis of the frog pituitary gland.
    Bercu BB; Brinkley HJ
    Experientia; 1969 Aug; 25(8):879-80. PubMed ID: 4900011
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic requirements for melanophore-stimulating hormone (MSH) secretion.
    Hadley ME; Bower SA
    Gen Comp Endocrinol; 1976 Feb; 28(2):118-30. PubMed ID: 1083822
    [No Abstract]   [Full Text] [Related]  

  • 19. The distribution of immunoreactive alpha-melanocyte-stimulating hormone cells in the adult human pituitary gland.
    Coates PJ; Doniach I; Hale AC; Rees LH
    J Endocrinol; 1986 Nov; 111(2):335-42. PubMed ID: 3025327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory activity of the intraocular homotransplanted pars intermedia of the frog, Rana nigromaculata.
    Ito T; Yeh WH; Nishiyama K
    Neuroendocrinology; 1986; 43(6):689-95. PubMed ID: 3762865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.